The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
about
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of lifeNonadherence to Medication Therapy in Haemodialysis Patients: A Systematic ReviewMedication adherence in schizophreniaChallenges in measuring outcomes for caregivers of people with mental health problemsAdherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature reviewFactors associated with medication adherence among patients with schizophrenia in Mekelle, Northern EthiopiaChanges in body weight and psychotropic drugs: a systematic synthesis of the literatureEffective Strategies for Nurses Empowering Clients With Schizophrenia: Medication Use as a Tool in Recovery.The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase.Missing clinical and behavioral health data in a large electronic health record (EHR) systemDevelopment and Feasibility Testing of a Smartphone Intervention to Improve Adherence to Antipsychotic Medications.Treatment compliance and noncompliance in psychoses.Approaches to improve adherence to pharmacotherapy in patients with schizophreniaEngagement-focused care during transitions from inpatient and emergency psychiatric facilities.Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.Access to credible information on schizophrenia patients' medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers.Strategies for monitoring outcomes in patients with bipolar disorderThe assessment of quality of life in clinical practice in patients with schizophrenia.Integrated neurobiology of bipolar disorder.Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand.Quality of life among caregivers of patients with schizophrenia: a cross-cultural comparison of Chilean and French families.The diagnosis and treatment of bipolar disorder: decision-making in primary care.Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatryA meta-analysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia.Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Comparing medication attitudes and reasons for medication nonadherence among three disparate groups of individuals with serious mental illnessComparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia.Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey.Quality of life is predictive of relapse in schizophrenia.Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nursesSecond-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder.Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophreniaGuidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.
P2860
Q26752965-01BCA35F-E0C0-458F-B69F-07531BC1FB05Q26774337-4D2BFA84-ECAB-4AF8-BEE2-699807257D1CQ26823655-AFA1595F-EA83-49C5-B30C-69D2A53FB5A3Q26828749-9374C78D-87B9-4A91-986F-DE4E8E2A03F1Q26859455-10ADD7E5-B502-4AFC-AF3E-8ABD21BC7306Q28545127-DCAA822E-1D35-4BBF-BA88-CA2DB09D5E44Q28728401-1CB47AC7-71DC-4A55-B1DC-C33271683B14Q30276915-FDA3583F-C982-44A5-8F4D-A02F69433256Q30933842-D4CDA400-6AEB-4914-871C-EA6CF2D99E8CQ31077469-7C34A3DF-DEB2-4441-B25B-129A8F467566Q33449854-6C0C8927-1B23-4A8A-92A8-E1D5790DFC75Q33641662-307B98D7-6FBA-4513-8029-9918599ADE63Q33645198-4D69E5D7-E921-4960-8710-A0A8D5934632Q33714101-D07D9F1B-C003-44ED-9665-F483E7A448B3Q33818732-58BD6E3C-CD27-4483-9D46-ACEEC2E3A63BQ33857710-625220E0-3C9F-413F-A4D8-13B8853FAF8DQ33879034-6E90CE09-7B99-4413-B736-92FB270D8F0AQ33985405-64E962ED-78B0-4D03-A4F4-5BE7AD83FF93Q34074662-F1A9AD65-BFE7-426D-85CC-C514D5AEE25BQ34080310-13FFCF92-FB9E-43CB-A152-E95089C32456Q34231559-5172A257-54CC-4A91-A7B0-A1CCEA03F73EQ34284317-48387D1E-2865-416D-B2CE-A4A93DA2807CQ34331882-9DF28BFD-3D20-493C-886A-E37428BD0300Q34357174-3C152FAC-58A1-4762-9FBA-4E42C2536078Q34385060-E68E94A1-E6EB-420B-B5FB-A13B4FA5C879Q34389967-9A2B0340-8801-4CC6-AAA4-62EAF99BA779Q34399261-C4ABE091-E71F-4A4B-B0C8-C988843D5F6BQ34418847-236A092A-9F47-439B-8AEB-F23261F3C4ADQ34430833-5608E8E8-E9E6-41C5-946F-A30B6B34FA03Q34436401-B728F63A-EB5D-46D1-9E6D-E5AD4A2A1FA7Q34486175-765C6A70-171A-45C1-8CFE-6C8C5E5DBA0BQ34516230-C0B5A925-0100-4D5A-B999-E4C0388450C7Q34542824-02412492-BB10-447F-97B6-50382CDE09CFQ34588656-BBC2AD5E-2206-40BF-81AE-81BCBF6F410DQ34620095-8E84C553-EFAC-469A-BFE6-8DF698A80898Q34650576-E02852CE-F50E-465E-A765-822D7A7DFEE8Q34774899-1D5C3571-1F16-42C5-BCF4-19964402394DQ34777367-2B12D9CB-7D04-4D88-AFD5-7806A192B75DQ35019258-34992F56-D1A9-44FB-9BDC-BCFD6003BDB4Q35073474-8B88CCEB-4AF2-4BE3-A8FC-ECA49831DFE3
P2860
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The expert consensus guideline ...... and persistent mental illness.
@en
The expert consensus guideline ...... and persistent mental illness.
@nl
type
label
The expert consensus guideline ...... and persistent mental illness.
@en
The expert consensus guideline ...... and persistent mental illness.
@nl
prefLabel
The expert consensus guideline ...... and persistent mental illness.
@en
The expert consensus guideline ...... and persistent mental illness.
@nl
P2093
P1476
The expert consensus guideline ...... and persistent mental illness
@en
P2093
Daniel Carpenter
Dawn I Velligan
Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness
John P Docherty
Martha Sajatovic
Peter J Weiden
P304
1-46; quiz 47-8
P478
70 Suppl 4
P577
2009-01-01T00:00:00Z